Exciting new clinical trial at SARRC: Memantine
SARRC's research department is currently accepting and screening participants for a new clinical trial. The purpose of this trial is to study the medication Memantine's effect on symptoms of autism. Memantine has been used to improve motor functioning, social responsivity, and also to reduce compulsivity.
Please contact Sharman in research at (602) 340-8717, extension 2100, for more information.
